4//SEC Filing
Callos Andrew 4
Accession 0001061983-25-000049
CIK 0001061983other
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 5:28 PM ET
Size
7.9 KB
Accession
0001061983-25-000049
Insider Transaction Report
Form 4
CYTOKINETICS INCCYTK
Callos Andrew
EVP, Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-12-08$39.13/sh+1,042$40,773→ 51,702 total - Sale
Common Stock
2025-12-08$65.96/sh−1,042$68,730→ 50,660 total - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2025-12-08−1,042→ 35,403 totalExercise: $39.13From: 2023-04-06Exp: 2033-03-06→ Common Stock (1,042 underlying)
Documents
Issuer
CYTOKINETICS INC
CIK 0001061983
Entity typeother
Related Parties
1- filerCIK 0001852129
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 5:28 PM ET
- Size
- 7.9 KB